Article | 2026 Retina Society Meeting
Avacincaptad Pegol and Anti-VEGF in Real-World Practice
An IRIS Registry analysis of more than 13,000 eyes found that concomitant anti-VEGF use for nAMD or CNV did not substantially alter complement inhibitor treatment.







